DOJ Seeks To Block Purdue Pharma Bankruptcy Deal

DOJ Seeks To Block Purdue Pharma Bankruptcy Deal That Shields The Sacklers The DOJ is seeking to block implementation of any part of the Purdue Pharma bankruptcy deal until legal challenges are settled. The deal granted Sackler family members immunity from opioid lawsuits. September 16, 2021.10:37 AM ET. A division of the Justice Department that serves as a watchdog over the federal bankruptcy system filed an appeal late Wednesday seeking to block the controversial Purdue Pharma bankruptcy plan. Throughout a two-week bankruptcy trial, and in court documents, the Justice Department repeatedly blasted releases from liability granted to the Sacklers as "Unlawful" and "Unconstitutional." In an earlier filing, Harrington accused the Sacklers and their associates of using the bankruptcy system to avoid liability for "Alleged wrongdoing in concocting and perpetuating for profit one of the most severe public health crises ever experienced in the United States." In new court documents filed Wednesday, attorneys for the Department of Justice signaled they are concerned some provisions of the Purdue Pharma bankruptcy plan might be implemented quickly, complicating an appeal. In approving the Purdue Pharma bankruptcy this month, the judge described it as the best possible resolution to a case involving more than 600,000 parties who say OxyContin harmed them.